Telomere shortening leads to earlier age of onset in ALS mice
Author(s) -
Birgit Linkus,
Diana Wiesner,
Martina Meßner,
Alexander Karabatsiakis,
Annika Scheffold,
K. Lenhard Rudolph,
Dietmar Rudolf Thal,
Jochen H. Weishaupt,
Albert C. Ludolph,
Karin M. Danzer
Publication year - 2016
Publication title -
aging
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.473
H-Index - 90
ISSN - 1945-4589
DOI - 10.18632/aging.100904
Subject(s) - telomerase , telomere , amyotrophic lateral sclerosis , genetically modified mouse , microglia , phenotype , knockout mouse , biology , transgene , immunology , medicine , cancer research , pathology , gene , genetics , inflammation , disease
Telomere shortening has been linked to a variety of neurodegenerative diseases. Recent evidence suggests that reduced telomerase expression results in shorter telomeres in leukocytes from sporadic patients with amyotrophic lateral sclerosis (ALS) compared with healthy controls. Here, we have characterized telomere length in microglia, astroglia and neurons in human post mortem brain tissue from ALS patients and healthy controls. Moreover, we studied the consequences of telomerase deletion in a genetic mouse model for ALS. We found a trend towards longer telomeres in microglia in the brains of ALS patients compared to non-neurologic controls. Knockout of telomerase leading to telomere shortening accelerated the ALS phenotype inSOD1G93A-transgenic mice. Our results suggest that telomerase dysfunction might contribute to the age-related risk for ALS.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom